Skip to search formSkip to main contentSkip to account menu

Neural Cell Adhesion Molecule 1

Known as: NCAM, CD56, NCAM-1 
Neural cell adhesion molecule 1 (761 aa, ~84 kDa) is encoded by the human NCAM1 gene. This protein is involved in the mediation of neuron-neuron… 
National Institutes of Health

Related topics

Related topics

14 relations
CD56 Expressing Cell MeasurementCell AdhesionClusters of differentiationLigand Binding

Broader (1)

Neural Cell Adhesion Molecules

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Natural killer cell function and expression of beta 7 integrin in psoriatic arthritis.
OBJECTIVE To examine the cytotoxic activity of natural killer (NK) cells from peripheral blood (PB) and synovial fluid (SF) of… 
1992
1992
Immunoarchitecture of normal human bone marrow: a study of frozen and fixed tissue sections.
1992
1992
Expression of CD56 (NKH‐1) differentiation antigen in human thyroid epithelium
Leu‐19 (CD56) MoAb is well known to recognize gp220 expressed on natural killer (NK) cells and is widely used as a NK cell marker… 
1991
1991
Detection of Leu-19 (CD56) antigen on human thyroid epithelial cells by an immunohistochemical method.
The Leu-19 (CD56) antigen, which is recognized by anti-Leu-19 and NKH-1 monoclonal antibody, is a 200,000-220,000 molecular… 
1991
1991
Expression of perforin by natural killer cells within first trimester endometrium in humans.
The lymphocyte pore-forming protein (PFP)--perforin, also named cytolysin--is a potent mediator of cytotoxicity found in the… 
1990
1990
Natural killer cell immunodeficiency in siblings: defective killing in the absence of natural killer cytotoxic factor activity in natural killer and lymphokine-activated killer cytotoxicities.
A immunodeficiency of natural killer cells as effectors for natural killer and lymphokine-activated killer cytotoxicities was… 
Highly Cited
1989
Highly Cited
1989
Natural killer (NK) cell activity of first trimester human decidua.
1989
1989
Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity.
Fifteen patients with advanced malignancy who had failed conventional therapy were entered into a protocol consisting of 1… 
1988
1988
Mechanism of K562-induced human natural killer cell inactivation using highly enriched effector cells isolated via a new single-step sheep erythrocyte rosette assay.
1987
1987
Modulation of ongoing human immunoglobulin synthesis by natural killer cells.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)